Cargando…
Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013–2014 malaria season
BACKGROUND: In 2006, the Senegalese National Malaria Control Programme recommended artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria. Since the introduction of ACT, there have been very few reports on the level of Plasmodium falciparum resistance to an...
Autores principales: | Fall, Bécaye, Camara, Cheikhou, Fall, Mansour, Nakoulima, Aminata, Dionne, Pierre, Diatta, Bakary, Diemé, Yaya, Wade, Boubacar, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334420/ https://www.ncbi.nlm.nih.gov/pubmed/25849097 http://dx.doi.org/10.1186/s12936-015-0589-3 |
Ejemplares similares
-
Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014
por: Fall, Bécaye, et al.
Publicado: (2016) -
Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012–2013
por: Torrentino-Madamet, Marylin, et al.
Publicado: (2014) -
Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014
por: Boussaroque, Agathe, et al.
Publicado: (2016) -
Plasmodium falciparum with Multidrug Resistance 1 Gene Duplications, Senegal
por: Pascual, Aurélie, et al.
Publicado: (2013) -
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na(+)/H(+) exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal
por: Pascual, Aurélie, et al.
Publicado: (2013)